Qvintip® - enabling scalable HPV screening
A clinically validated self-sampling device designed for public health implementation at scale.
Qvintip® is a clinically validated, single-use self-sampling device that allows women to collect cervical and vaginal samples comfortably and safely for HPV testing.
The device features a detachable tip for secure transfer of the collected sample to a laboratory for analysis. Qvintip is a Swedish innovation, protected by patents and trademarked, with more than 20 years of clinical evaluation supporting its performance.
✔ Easy to use, highly acceptable
Simple, non-invasive self-collection that increases screening participation.
✔ Clinically validated performance
High sensitivity and specificity across leading PCR-based HPV assays.
✔ Regulatory ready
CE-marked, IVDR Class A, ISO 13485 certified.
✔ Built for scale
Dry transport, stable at room temperature for ≥30 days, 5-year shelf life.
✔ Adapted for low-resource settings
No electricity required, simple visual instructions, suitable for decentralized and home-based programs.
Self-Sampling Step-by-Step
COLLECT SAMPLE
LET DRY & SEAL CONTAINER
SEND TO LAB FOR ANALYSIS
Clinically validated. Scientifically grounded.
-
Very positive results from evaluation of Qvintip® were suggesting that a clear majority (63%) of women prefer Qvintip® over other self-sampling devices.
— Jentsche, 2016
-
The overall agreement of HPV detection between vaginal and cervical samples was excellent.
— Benczik et al., 2016
-
Screening with Qvintip is cost-effective for population-based cervical cancer prevention with the potential to improve health benefits to a lower cost than HPV reflex, conventional cytologi and repeat Pap smear.
— Professor Sonia Andersson, Karolinska Institute, Sweden